July 10, 2025 Hospital Services – Coverage of Gene Therapies for Sickle Cell Disease LAC 50:V.120

Baton Rouge, Louisiana, Jul 10, 2025 - Hospital Services – Coverage of Gene Therapies for Sickle Cell Disease                   LAC 50:V.120

Continues the July 1, 2025 Emergency Rule which adopted cell and gene therapy model that provides additional supplemental and federal rebates for gene therapies for sickle cell disease.

Contact Information: Kimberly Sullivan, Bureau of Health Services Financing, P.O. Box 91030, Baton Rouge, LA 70821-9030

Disclaimer:  Please note that the official versions of the Notices of Intent are maintained by the Office of State Register’s website at http://www.doa.louisiana.gov/osr/osr.htm.  The excerpted versions of these Notices of Intent contained on this website are provided as a courtesy service to the public and is unofficial and should not be regarded as such. Users are encouraged to visit the Office of State Register’s website for the official version.

Emergency Rule

July 1, 2025

Notice of Intent

Prior to Proposed Rule:  N/A

Proposed Rule:

July 20, 2025 (Louisiana Register)